{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T18:01:48Z","timestamp":1775325708448,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2014,3,8]],"date-time":"2014-03-08T00:00:00Z","timestamp":1394236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s12072-014-9516-x","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T04:48:59Z","timestamp":1394167739000},"page":"475-480","source":"Crossref","is-referenced-by-count":11,"title":["New drug targets for alcoholic liver disease"],"prefix":"10.1007","volume":"8","author":[{"given":"Mingjiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binxia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,8]]},"reference":[{"key":"9516_CR1","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","volume":"141","author":"B Gao","year":"2011","unstructured":"Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572\u20131585","journal-title":"Gastroenterology"},{"key":"9516_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-nutr-072610-145138","volume":"32","author":"HJ Wang","year":"2012","unstructured":"Wang HJ, Gao B, Zakhari S, Nagy LE. Inflammation in alcoholic liver disease. Annu Rev Nutr 2012;32:343\u2013368","journal-title":"Annu Rev Nutr"},{"key":"9516_CR3","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009;360:2758\u20132769","journal-title":"N Engl J Med"},{"key":"9516_CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","volume":"60","author":"P Mathurin","year":"2011","unstructured":"Mathurin P, O\u2019Grady J, Carithers RL, Phillips M, Louvet A, Mendenhall CL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut 2011;60:255\u2013260","journal-title":"Gut"},{"key":"9516_CR5","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","volume":"365","author":"E Nguyen-Khac","year":"2011","unstructured":"Nguyen-Khac E, Thevenot T, Piquet MA, Benferhat S, Goria O, Chatelain D, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med 2011;365:1781\u20131789","journal-title":"N Engl J Med"},{"key":"9516_CR6","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gtc.2011.06.008","volume":"40","author":"AK Singal","year":"2011","unstructured":"Singal AK, Shah VH. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am 2011;40:611\u2013639","journal-title":"Gastroenterol Clin North Am"},{"key":"9516_CR7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2009.12.045","volume":"53","author":"E Christensen","year":"2010","unstructured":"Christensen E. Glucocorticosteroids in acute alcoholic hepatitis: the evidence of a beneficial effect is getting even weaker. J Hepatol 2010;53:390\u2013391","journal-title":"J Hepatol"},{"key":"9516_CR8","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/thorax.57.10.875","volume":"57","author":"RH Green","year":"2002","unstructured":"Green RH, Brightling CE, Woltmann G, Parker D, Wardlaw AJ, Pavord ID. Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax 2002;57:875\u2013879","journal-title":"Thorax"},{"key":"9516_CR9","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.4049\/jimmunol.154.9.4719","volume":"154","author":"G Cox","year":"1995","unstructured":"Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 1995;154:4719\u20134725","journal-title":"J Immunol"},{"key":"9516_CR10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","volume":"317","author":"RC Bone","year":"1987","unstructured":"Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653\u2013658","journal-title":"N Engl J Med"},{"key":"9516_CR11","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/hep.26334","volume":"58","author":"F Lin","year":"2013","unstructured":"Lin F, Taylor NJ, Su H, Huang X, Hussain MJ, Abeles RD, et al. Alcohol dehydrogenase-specific T-cell responses are associated with alcohol consumption in patients with alcohol-related cirrhosis. Hepatology 2013;58:314\u2013324","journal-title":"Hepatology"},{"key":"9516_CR12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/gut.20.12.1109","volume":"20","author":"AR Tanner","year":"1979","unstructured":"Tanner AR, Powell LW. Corticosteroids in liver disease: possible mechanisms of action, pharmacology, and rational use. Gut 1979;20:1109\u20131124","journal-title":"Gut"},{"key":"9516_CR13","author":"HJ Kwon","year":"2013","unstructured":"Kwon HJ, Won YS, Park O, Feng D, Gao B. Opposing effects of prednisolone treatment on T\/NKT cell- and hepatotoxin-mediated hepatitis in mice. Hepatology 2013;. doi: 10.1002\/hep.26748","journal-title":"Hepatology"},{"key":"9516_CR14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","volume":"136","author":"M Dominguez","year":"2009","unstructured":"Dominguez M, Miquel R, Colmenero J, Moreno M, Garcia-Pagan JC, Bosch J, et al. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis. Gastroenterology 2009;136:1639\u20131650","journal-title":"Gastroenterology"},{"key":"9516_CR15","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/j.gastro.2006.12.036","volume":"132","author":"J Colmenero","year":"2007","unstructured":"Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, et al. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity. Gastroenterology 2007;132:687\u2013697","journal-title":"Gastroenterology"},{"key":"9516_CR16","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/hep.26419","volume":"58","author":"A Bertola","year":"2013","unstructured":"Bertola A, Park O, Gao B. Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury: a critical role for E-selectin. Hepatology 2013;58:1814\u20131823","journal-title":"Hepatology"},{"key":"9516_CR17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.510240311","volume":"24","author":"DH Adams","year":"1996","unstructured":"Adams DH, Hubscher SG, Fisher NC, Williams A, Robinson M. Expression of E-selectin and E-selectin ligands in human liver inflammation. Hepatology 1996;24:533\u2013538","journal-title":"Hepatology"},{"key":"9516_CR18","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.24599","volume":"54","author":"P Mandrekar","year":"2011","unstructured":"Mandrekar P, Ambade A, Lim A, Szabo G, Catalano D. An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice. Hepatology 2011;54:2185\u20132197","journal-title":"Hepatology"},{"key":"9516_CR19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/hep.24701","volume":"55","author":"R Urtasun","year":"2012","unstructured":"Urtasun R, Lopategi A, George J, Leung TM, Lu Y, Wang X, et al. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K\/pAkt\/NFkappaB signaling. Hepatology 2012;55:594\u2013608","journal-title":"Hepatology"},{"key":"9516_CR20","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.25758","volume":"56","author":"J Pritchett","year":"2012","unstructured":"Pritchett J, Harvey E, Athwal V, Berry A, Rowe C, Oakley F, et al. Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans. Hepatology 2012;56:1108\u20131116","journal-title":"Hepatology"},{"key":"9516_CR21","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/hep.26521","volume":"58","author":"O Morales-Ibanez","year":"2013","unstructured":"Morales-Ibanez O, Dominguez M, Ki SH, Marcos M, Chaves JF, Nguyen-Khac E, et al. Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis. Hepatology 2013;58:1742\u20131756","journal-title":"Hepatology"},{"key":"9516_CR22","author":"X Ge","year":"2013","unstructured":"Ge X, Leung TM, Arriazu E, Lu Y, Urtasun R, Christensen B, et al. Osteopontin binding to lipopolysaccharide lowers tumor necrosis factor-alpha and prevents early alcohol-induced liver injury in mice. Hepatology 2013;. doi: 10.1002\/hep.26931","journal-title":"Hepatology"},{"key":"9516_CR23","doi-asserted-by":"crossref","first-page":"834A","DOI":"10.1002\/hep.26215","volume":"58","author":"R Lazaro","year":"2013","unstructured":"Lazaro R, Ueno A, Do R, Zhu L, Wu R, Xu J, et al. Mouse model of alcoholic hepatitis: no role of osteopontin. Hepatology 2013;58:834A","journal-title":"Hepatology"},{"key":"9516_CR24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fphys.2012.00402","volume":"3","author":"P Hartmann","year":"2012","unstructured":"Hartmann P, Chen WC, Schnabl B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol 2012;3:402","journal-title":"Front Physiol"},{"key":"9516_CR25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.26321","volume":"58","author":"P Hartmann","year":"2013","unstructured":"Hartmann P, Chen P, Wang HJ, Wang L, McCole DF, Brandl K, et al. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology 2013;58:108\u2013119","journal-title":"Hepatology"},{"key":"9516_CR26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/hep.24018","volume":"53","author":"AW Yan","year":"2011","unstructured":"Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, Schott E, et al. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011;53:96\u2013105","journal-title":"Hepatology"},{"key":"9516_CR27","first-page":"175","volume":"632","author":"MT Pritchard","year":"2008","unstructured":"Pritchard MT, McMullen MR, Medof ME, Stavitsky A, Nagy LE. Role of complement in ethanol-induced liver injury. Adv Exp Med Biol 2008;632:175\u2013186","journal-title":"Adv Exp Med Biol"},{"key":"9516_CR28","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/hep.26336","volume":"57","author":"S Mathews","year":"2013","unstructured":"Mathews S, Gao B. Therapeutic potential of interleukin 1 inhibitors in the treatment of alcoholic liver disease. Hepatology 2013;57:2078\u20132080","journal-title":"Hepatology"},{"key":"9516_CR29","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","volume":"122","author":"J Petrasek","year":"2012","unstructured":"Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012;122:3476\u20133489","journal-title":"J Clin Invest"},{"key":"9516_CR30","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1053\/j.gastro.2008.02.022","volume":"134","author":"Y Jung","year":"2008","unstructured":"Jung Y, Brown KD, Witek RP, Omenetti A, Yang L, Vandongen M, et al. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans. Gastroenterology 2008;134:1532\u20131543","journal-title":"Gastroenterology"},{"key":"9516_CR31","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.25614","volume":"55","author":"P Sancho-Bru","year":"2012","unstructured":"Sancho-Bru P, Altamirano J, Rodrigo-Torres D, Coll M, Millan C, Jose Lozano J, et al. Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis. Hepatology 2012;55:1931\u20131941","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"9516_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1746.2011.07003.x","volume":"27","author":"B Gao","year":"2012","unstructured":"Gao B. Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol 2012;27(Suppl 2):89\u201393","journal-title":"J Gastroenterol Hepatol"},{"key":"9516_CR33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","volume":"56","author":"X Kong","year":"2012","unstructured":"Kong X, Feng D, Wang H, Hong F, Bertola A, Wang FS, et al. Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice. Hepatology 2012;56:1150\u20131159","journal-title":"Hepatology"},{"issue":"765\u2013776","key":"9516_CR34","first-page":"e761","volume":"143","author":"F Meng","year":"2012","unstructured":"Meng F, Wang K, Aoyama T, Grivennikov SI, Paik Y, Scholten D, et al. Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology 2012;143:765\u2013776","journal-title":"Gastroenterology"},{"key":"9516_CR35","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","volume":"39","author":"S Radaeva","year":"2004","unstructured":"Radaeva S, Sun R, Pan HN, Hong F, Gao B. Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 2004;39:1332\u20131342","journal-title":"Hepatology"},{"key":"9516_CR36","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.23837","volume":"52","author":"SH Ki","year":"2010","unstructured":"Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010;52:1291\u20131300","journal-title":"Hepatology"},{"key":"9516_CR37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.it.2012.01.003","volume":"33","author":"SJ Rubino","year":"2012","unstructured":"Rubino SJ, Geddes K, Girardin SE. Innate IL-17 and IL-22 responses to enteric bacterial pathogens. Trends Immunol 2012;33:112\u2013118","journal-title":"Trends Immunol"},{"key":"9516_CR38","unstructured":"Xu M, Feng D, Wang H, Guan Y, Yan X, Gao B. Interleukin-22 ameliorates renal ischemia-reperfusion injury via the activation of STAT3 and AKT in the renal proximal tubule epithelial cells. J Am Soc Nephrol 2013; in press"},{"key":"9516_CR39","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.24339","volume":"54","author":"O Park","year":"2011","unstructured":"Park O, Wang H, Weng H, Feigenbaum L, Li H, Yin S, et al. In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 2011;54:252\u2013261","journal-title":"Hepatology"},{"key":"9516_CR40","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2741\/1765","volume":"10","author":"AE Feldstein","year":"2005","unstructured":"Feldstein AE, Gores GJ. Apoptosis in alcoholic and nonalcoholic steatohepatitis. Front Biosci 2005;10:3093\u20133099","journal-title":"Front Biosci"},{"key":"9516_CR41","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.26200","volume":"57","author":"S Roychowdhury","year":"2013","unstructured":"Roychowdhury S, McMullen MR, Pisano SG, Liu X, Nagy LE. Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury. Hepatology 2013;57:1773\u20131783","journal-title":"Hepatology"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9516-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-014-9516-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-014-9516-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:33:35Z","timestamp":1746146015000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-014-9516-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,8]]},"references-count":41,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["9516"],"URL":"https:\/\/doi.org\/10.1007\/s12072-014-9516-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,8]]}}}